AXQ Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,638
Closed -$2.43M 1185
2026
Q1
$2.43M Buy
2,638
+949
+56% +$962K 0.31% 72
2025
Q4
$1.82M Buy
+1,689
New +$1.61M 0.41% 39
2024
Q4
Sell
-3,304
Closed -$2.93M 546
2024
Q3
$2.93M Buy
+3,304
New +$2.97M 0.88% 4
2023
Q4
Sell
-3,400
Closed -$1.83M 747
2023
Q3
$1.83M Buy
+3,400
New +$1.75M 0.64% 18
2023
Q2
Sell
-1,000
Closed -$343K 452
2023
Q1
$343K Buy
+1,000
New +$337K 0.14% 267

Other funds holding LLY

AXQ Capital's LLY Position: Q2 2026 in Review

AXQ Capital sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 2,638 shares — an estimated $2.43M sold.

AXQ Capital first reported a position in LLY in Q1 2023 and held it in 5 quarters. The position peaked at $2.93M in Q3 2024. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • AXQ Capital reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • AXQ Capital sold 2,638 Eli Lilly shares in Q2 2026, an estimated $2.43M.
  • AXQ Capital first reported a position in Eli Lilly in Q1 2023 and held it in 5 quarters.
  • AXQ Capital's Eli Lilly position peaked at $2.93M in Q3 2024.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.